Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

2.

HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway.

Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rütten H, Fichtlscherer S, Martin H, Zeiher AM.

J Clin Invest. 2001 Aug;108(3):391-7.

3.

Pharmacological approaches to improve endothelial repair mechanisms.

Besler C, Doerries C, Giannotti G, Lüscher TF, Landmesser U.

Expert Rev Cardiovasc Ther. 2008 Sep;6(8):1071-82. doi: 10.1586/14779072.6.8.1071. Review.

PMID:
18793110
4.

HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells.

Llevadot J, Murasawa S, Kureishi Y, Uchida S, Masuda H, Kawamoto A, Walsh K, Isner JM, Asahara T.

J Clin Invest. 2001 Aug;108(3):399-405.

5.

Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells.

Thum T, Fraccarollo D, Galuppo P, Tsikas D, Frantz S, Ertl G, Bauersachs J.

Cardiovasc Res. 2006 Apr 1;70(1):50-60. Epub 2006 Feb 9.

PMID:
16480696
6.

Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis.

Laufs U, Werner N, Link A, Endres M, Wassmann S, Jürgens K, Miche E, Böhm M, Nickenig G.

Circulation. 2004 Jan 20;109(2):220-6. Epub 2003 Dec 22.

7.
8.

Statins, HMG-CoA Reductase Inhibitors, Improve Neovascularization by Increasing the Expression Density of CXCR4 in Endothelial Progenitor Cells.

Chiang KH, Cheng WL, Shih CM, Lin YW, Tsao NW, Kao YT, Lin CT, Wu SC, Huang CY, Lin FY.

PLoS One. 2015 Aug 26;10(8):e0136405. doi: 10.1371/journal.pone.0136405. eCollection 2015.

9.

Physiologic ischaemic training induces endothelial progenitor cell mobilization and myocardial angiogenesis via endothelial nitric oxide synthase related pathway in rabbits.

Xiao M, Lu X, Li J, Li L, Li Y.

J Cardiovasc Med (Hagerstown). 2014 Apr;15(4):280-7. doi: 10.2459/JCM.0b013e32836009fe.

PMID:
23507724
10.

Effects of statins on endothelium and endothelial progenitor cell recruitment.

Walter DH, Dimmeler S, Zeiher AM.

Semin Vasc Med. 2004 Nov;4(4):385-93. Review.

PMID:
15861319
11.

Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease.

Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, Dimmeler S.

Circulation. 2001 Jun 19;103(24):2885-90.

12.

Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine.

Thum T, Tsikas D, Stein S, Schultheiss M, Eigenthaler M, Anker SD, Poole-Wilson PA, Ertl G, Bauersachs J.

J Am Coll Cardiol. 2005 Nov 1;46(9):1693-701. Epub 2005 Oct 10.

13.

The effects of HMG-CoA reductase inhibitor on vascular progenitor cells.

Kusuyama T, Omura T, Nishiya D, Enomoto S, Matsumoto R, Murata T, Takeuchi K, Yoshikawa J, Yoshiyama M.

J Pharmacol Sci. 2006 Aug;101(4):344-9. Epub 2006 Aug 5.

14.

Effects of statins on endothelium and their contribution to neovascularization by mobilization of endothelial progenitor cells.

Walter DH, Zeiher AM, Dimmeler S.

Coron Artery Dis. 2004 Aug;15(5):235-42. Review.

PMID:
15238818
15.

Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy.

Rosenson RS.

Am J Cardiovasc Drugs. 2001;1(6):411-20. Review.

PMID:
14728000
16.

Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease.

Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S.

Circ Res. 2001 Jul 6;89(1):E1-7.

17.

Simvastatin increases circulating endothelial progenitor cells and reduces the formation and progression of diabetic retinopathy in rats.

Zhang W, Yan H.

Exp Eye Res. 2012 Dec;105:1-8. doi: 10.1016/j.exer.2012.09.014. Epub 2012 Oct 8.

PMID:
23059402
18.

Endothelial progenitor cell mobilization and increased intravascular nitric oxide in patients undergoing cardiac rehabilitation.

Paul JD, Powell TM, Thompson M, Benjamin M, Rodrigo M, Carlow A, Annavajjhala V, Shiva S, Dejam A, Gladwin MT, McCoy JP, Zalos G, Press B, Murphy M, Hill JM, Csako G, Waclawiw MA, Cannon RO 3rd.

J Cardiopulm Rehabil Prev. 2007 Mar-Apr;27(2):65-73.

PMID:
17558240
19.

Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury.

Iwakura A, Luedemann C, Shastry S, Hanley A, Kearney M, Aikawa R, Isner JM, Asahara T, Losordo DW.

Circulation. 2003 Dec 23;108(25):3115-21. Epub 2003 Dec 15.

20.

Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9.

Iwakura A, Shastry S, Luedemann C, Hamada H, Kawamoto A, Kishore R, Zhu Y, Qin G, Silver M, Thorne T, Eaton L, Masuda H, Asahara T, Losordo DW.

Circulation. 2006 Mar 28;113(12):1605-14. Epub 2006 Mar 13.

Supplemental Content

Support Center